Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
InSilico Medicine Hong Kong Limited
Verismo Therapeutics
SpringWorks Therapeutics, Inc.
IDEAYA Biosciences
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Nurix Therapeutics, Inc.
Context Therapeutics Inc.
Memorial Sloan Kettering Cancer Center
Oncovir, Inc.
Ascentage Pharma Group Inc.
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
University of Pennsylvania
Erasmus Medical Center
Checkpoint Therapeutics, Inc.
BerGenBio ASA
Suzhou Maximum Bio-tech Co., Ltd.
Ikena Oncology
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
University of Chicago
UTC Therapeutics Inc.
Prelude Therapeutics
Centre Hospitalier Universitaire Vaudois
National Institutes of Health Clinical Center (CC)
Multitude Therapeutics Inc.
Seagen Inc.
Mabpro, a.s.
Quadriga Biosciences, Inc.
Assistance Publique Hopitaux De Marseille
M.D. Anderson Cancer Center
Augusta University
Eli Lilly and Company
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Dana-Farber Cancer Institute
Aduro Biotech, Inc.
Abramson Cancer Center at Penn Medicine
Incyte Corporation
University of Pennsylvania
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Chicago
University of Pennsylvania